Company profile

OpenEvidence

America's Official Medical Knowledge Platform — AI-powered clinical decision support grounded in peer-reviewed medical literature

Generative AI & Healthcare Infrastructure

Company profile

About OpenEvidence

OpenEvidence is a medical AI platform that organizes and expands the world's collective medical knowledge for healthcare professionals. Founded on the principle of 'gold in, gold out,' the platform uses specialized AI models trained exclusively on peer-reviewed medical literature rather than the open internet, ensuring every answer is grounded in verifiable sources. The company has established official content partnerships with The New England Journal of Medicine (NEJM), JAMA and the JAMA Network, the National Comprehensive Cancer Network (NCCN), Cochrane Systematic Reviews, Wiley's portfolio of 400+ medical journals, and leading medical societies including ACC, ADA, AAFP, NORD, ACOG, AUA, AAO, and ACEP. As of 2025, OpenEvidence is actively used daily by over 40% of U.S. physicians across more than 10,000 hospitals and medical centers nationwide, with more than 25,000 verified U.S. doctors registering each month. The platform provides natural-language search capabilities that allow clinicians to access evidence-based recommendations, clinical guidelines, and peer-reviewed research at the point of care. OpenEvidence has expanded beyond search to include OpenEvidence Visits for clinical documentation and the AI-Integrated Doctor Dialer for HIPAA-secure telemedicine communications, messaging, faxing, and voicemail. The platform is free and unlimited for verified U.S. healthcare professionals and is available via web and mobile app.

Company description OpenEvidence official website

Mission. OpenEvidence's mission is to organize and expand the world's collective medical knowledge.

Primary marketGenerative AI & Healthcare Infrastructure
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at OpenEvidence?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • cardiology
  • dermatology
  • endocrinology
  • gastroenterology
  • geriatrics
  • hematology
  • internal medicine
  • neurology
  • obstetrics
  • oncology
  • psychiatry
  • rheumatology

Who it serves

  • healthcare professionals
  • hospitals
  • medical centers
  • physicians

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

February 2025: Multi-year content agreement with NEJM Group. November 2025: Licensing agreement with NCCN for oncology guidelines. March 2026: Strategic partnership with Wiley for 400+ journals including Cochrane. February 2026: Wide release of AI-Integrated Doctor Dialer with messaging, faxing, and voicemail capabilities.

Partnerships

Recorded partners

  • American Academy of Family Physicians (AAFP)
  • American Academy of Ophthalmology (AAO)
  • American College of Cardiology (ACC)
  • American College of Emergency Physicians (ACEP)
  • American College of Obstetricians and Gynecologists (ACOG)
  • American Diabetes Association (ADA)
  • American Urological Association (AUA)
  • Cochrane
  • JAMA and JAMA Network
  • Mayo Clinic
  • National Comprehensive Cancer Network (NCCN)
  • National Organization for Rare Disorders (NORD)
  • NEJM Group
  • Wiley

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Doctor Dialer

AI-integrated HIPAA-secure telemedicine communications suite for doctor-patient interactions

Platform · Cloud SaaSCompany source

OpenEvidence

AI-powered medical search and clinical decision support platform for physicians

Platform · Cloud SaaSCompany source

OpenEvidence Mobile App

Mobile medical AI platform for healthcare professionals

Software · Cloud SaaSCompany source

OpenEvidence Visits

AI-powered clinical documentation and visit management system

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

40% of U.S. physicians use platform daily

Physician adoption rate

10,000+ hospitals and medical centers

Healthcare facility reach

25,000+ verified U.S. doctors registering monthly

Growth rate

37 million minutes of doctor-patient care communications

Usage of Dialer and Visits suite

Fastest platform to surpass 100,000 verified doctor users

Adoption speed in medical industry history

U.S. Healthcare Professionals (telemedicine)

Doctor-patient telemedicine communications and clinical documentation

Approximately 37 million minutes of doctor-patient care communications and interactions powered by OpenEvidence Dialer and Visits

U.S. Physicians (aggregate)

Clinical decision support and medical search at point of care across 10,000+ hospitals and medical centers

Over 40% of U.S. physicians actively use OpenEvidence daily, with 25,000+ verified U.S. doctors registering each month

Mayo Clinic

Reducing physician time spent searching for and gathering clinical information

Physicians can spend less time searching for information and more time with patients by accessing multimedia and information from leading clinical journals

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Antonio Jorge Forte

Director of MayoExpert, Mayo Clinic

LinkedIn

06 · Company updates

Updates from OpenEvidence

Recent articles published on OpenEvidence's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

Johns Hopkins Partners with AI Platform to Reimagine Medical Training for the Algorithm Age

The institution that shaped modern medical education a century ago is now collaborating with OpenEvidence to prepare physicians for AI-augmented clinical practice while preserving core diagnostic reasoning skills.

Read on HAIC

AI Giants Team Up to Deliver Free Medical Decision Support to 100 Developing Nations

Anthropic and OpenEvidence are launching a global health equity initiative to bring evidence-based clinical tools to physicians in resource-limited settings across Africa, Asia, and Latin America.

Read on HAIC

Memorial Sloan Kettering's Genomic Expertise Gets AI Wings as OpenEvidence Targets 1.12 Million Clinicians

A $15 billion clinical AI company is embedding the cancer center's precision oncology knowledge base directly into physician workflows, aiming to democratize expert genomic interpretation beyond academic medical centers.

Read on HAIC

Clinical Documentation Giant Abridge Makes Bold Play for Revenue Cycle Dominance with Pre-Bill AI Tool

The ambient documentation leader is leveraging its foothold in 300 U.S. health systems to tackle the $450 million coding automation market with claim review technology that catches billing errors before submission.

Read on HAIC

Inside Sutter Health's Blueprint for Enterprise AI: From Radiology Workflows to Patient Chatbots

Northern California's 3.5-million-patient health system is deploying ambient scribes, AI-powered imaging, and clinical decision support tools while building governance frameworks to maintain clinician and patient trust.

Read on HAIC

Medical AI Achieves Perfect Score on Clinical Benchmark as OpenEvidence Unveils Four-Model Suite for Physicians

Darwin model leads new family of specialized clinical AI tools designed to balance speed and depth across different healthcare workflows, now available free to verified clinicians.

Read on HAIC

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Generative AI & Healthcare Infrastructure

Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon